A systematic review of the global intervention for SARS-CoV-2 combating: from drugs repurposing to molnupiravir approval

NA Ashour, A Abo Elmaaty, AA Sarhan… - Drug design …, 2023 - Taylor & Francis
The rising outbreak of SARS-CoV-2 continues to unfold all over the world. The development
of novel effective antiviral drugs to fight against SARS-CoV-2 is a time cost. As a result, some …

[HTML][HTML] Interaction of SARS-CoV-2 with cardiomyocytes: Insight into the underlying molecular mechanisms of cardiac injury and pharmacotherapy

A Abdi, S AlOtaiby, F Al Badarin, A Khraibi… - Biomedicine & …, 2022 - Elsevier
SARS-CoV-2 causes respiratory illness with a spectrum of systemic complications. However,
the mechanism for cardiac infection and cardiomyocyte injury in COVID-19 patients remains …

A nanomaterial targeting the spike protein captures SARS-CoV-2 variants and promotes viral elimination

G Zhang, Y Cong, FL Liu, J Sun, J Zhang, G Cao… - Nature …, 2022 - nature.com
The global emergency caused by the severe acute respiratory syndrome coronavirus 2
(SARS-CoV-2) pandemic can only be solved with effective and widespread preventive and …

Controlled randomized clinical trial on using Ivermectin with Doxycycline for treating COVID-19 patients in Baghdad, Iraq

HA Hashim, MF Maulood, AM Rasheed, DF Fatak… - MedRxiv, 2020 - medrxiv.org
Objectives COVID-19 patients suffer from the lack of curative therapy. Hence, there is an
urgent need to try repurposed old drugs on COVID-19. Methods Randomized controlled …

Defining the Syrian hamster as a highly susceptible preclinical model for SARS-CoV-2 infection

K Rosenke, K Meade-White, M Letko… - Emerging microbes & …, 2020 - Taylor & Francis
Following emergence in late 2019, SARS-CoV-2 rapidly became pandemic and is presently
responsible for millions of infections and hundreds of thousands of deaths worldwide. There …

COVID-19 lung pathogenesis in SARS-CoV-2 autopsy cases

S Valdebenito, S Bessis, D Annane… - Frontiers in …, 2021 - frontiersin.org
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a major public health
issue. COVID-19 is considered an airway/multi-systemic disease, and demise has been …

The efficacy of curcumin-piperine co-supplementation on clinical symptoms, duration, severity, and inflammatory factors in COVID-19 outpatients: a randomized …

G Askari, A Sahebkar, D Soleimani, A Mahdavi… - Trials, 2022 - Springer
Background COVID-19 pandemic has made the disease a major global problem by creating
a significant burden on health, economic, and social status. To date, there are no effective …

[HTML][HTML] SARS-CoV-2: immune response elicited by infection and development of vaccines and treatments

G Canedo-Marroquin, F Saavedra… - Frontiers in …, 2020 - frontiersin.org
The World Health Organization (WHO) announced in March a pandemic caused by Severe
Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2). This new infectious disease was …

[HTML][HTML] Hydroxychloroquine/chloroquine as therapeutics for COVID-19: truth under the mystery

Y Chen, MX Li, GD Lu, HM Shen… - International Journal of …, 2021 - ncbi.nlm.nih.gov
The outbreak of coronavirus disease-19 (COVID-19) caused by severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2) has rapidly evolved into a global pandemic. One …

[HTML][HTML] Acceptance rates and beliefs toward COVID-19 vaccination among the general population of Pakistan: a cross-sectional survey

F Yasmin, W Asghar, MS Babar, H Khan… - The American journal …, 2021 - ncbi.nlm.nih.gov
Developing countries like Pakistan have previously suffered from barriers to acceptance of
vaccination by the public because of financial and belief barriers. This study aims to explore …